Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

July 23, 2025

Primary Completion Date

October 30, 2026

Study Completion Date

December 30, 2026

Conditions
General Anesthesia
Interventions
DRUG

Tegoprazan

Tegoprazan OD tab. 50 mg PO + Saline 20ml IV, one hour before general anesthesia.

DRUG

Famotidine

Famotidine 20mg/10ml+saline 10ml IV + Tegoprazan OD tab. 50 mg placebo PO, one hour before general anesthesia.

DRUG

Placebo

Tegoprazan OD tab. 50 mg placebo PO + Saline 20ml IV, one hour before general anesthesia.

Trial Locations (1)

Unknown

Korea University Medical Center, Guro Hospital, Seoul

All Listed Sponsors
collaborator

Korea University Guro Hospital

OTHER

collaborator

HK inno.N Corporation

INDUSTRY

collaborator

Eunpyeong St. Mary's Hospital, The Catholic University of Korea

UNKNOWN

collaborator

Asan Medical Center

OTHER

lead

Seok Kyeong Oh

OTHER

NCT06743243 - Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia | Biotech Hunter | Biotech Hunter